Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

计划入组 705 人 · 首次发布于 2023 年 11 月 18 日

Functional Instability in Patients Suffering From Collagen Disease and Joint Hypermobility

计划入组 30 人 · 首次发布于 2023 年 5 月 23 日

Detecting Fluid Accumulation With a Wearable Bioimpedance Sensor

计划入组 24 人 · 首次发布于 2023 年 9 月 26 日

Ostabolin (Zelos)

VLA-4/VCAM-1 inhibitors (University of the Basque Country)

HEALTH FOUNDRY PTY LTD

Australia

United Microelectronics

ACM Research

United States

Delos Capital and AP Biosciences Launch Strategic Partnership to Accelerate Next-Generation Antibody Development

Penn Launches $18 Million AI-Driven RNA Foundry to Democratize mRNA Technology Beyond Vaccines

TRexBio Secures $84 Million in Series B Funding to Advance TNFR2 Agonist TRB-061